Drug Trial Radar · NCT07902245
Phase 1 Study to Evaluate RG002C0106 Injection in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 10, 2026
Primary completion
Mar 31, 2028
Study completion Mar 31, 2028
Sponsor
- Lead sponsor
- Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if RG002C0106 is safe in healthy participants . It will also learn about how the drug is absorbed, distributed, metablized and excrited. The main questions it aims to answer are: What medical problems do participants have when taking RG002C0106? Researchers will compare RG002C0106 to a placebo (a look-alike substance that contains no drug) to see if RG002C0106 is safe to participants. Participants will: Take RG00C2C0106 or a placebo once. Visit the clinic once every 2 weeks/1 month for checkups and tests.
Conditions
- Safety Issues
Interventions
RG002C0106Drug
At Day 1, each participants will be given one dose of RG002C0106 Injection.
0.9% sodium chloride injectionDrug
At Day 1, each participants will be given one dose of 0.9% sodium chloride injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidences of adverse events (AEs) and serious adverse events (SAEs) related to the investigational drug.Time frame: within 169 days after the administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novatrials
City of Lake Macquarie, New South Wales, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.